Publications

TGFβR signalling controls CD103+CD11b+ dendritic cell development in the intestine

Bain CC, Montgomery J, Scott CL, Kel JM, Girard-Madoux MJH, Martens L, Zangerle-Murray TFP, Ober-Blöbaum J, Lindenbergh-Kortleve D, Samsom JN, Henri S, Lawrence T, Saeys Y, Malissen B, Dalod M, Clausen BE, Mowat AM., Nat Commun., 2017, 8(1):620, PMID: 28931816

Natural-Killer-like B Cells Display the Phenotypic and Functional Characteristics of Conventional B Cells

Kerdiles YM, Almeida FF, Thompson T, Chopin M, Vienne M, Bruhns P, Huntington ND, Raulet DH, Nutt SL, Belz GT, Vivier E., Immunity, 2017, 47(2):199-200, PMID: 28813647

Innate lymphoid cells: major players in inflammatory diseases

Ebbo M, Crinier A, Vély F, Vivier E., Nat Rev Immunol., 2017, PMID: 28804130

T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation

Kwong B, Rua R, Gao Y, Flickinger J Jr, Wang Y, Kruhlak MJ, Zhu J, Vivier E, McGavern DB, Lazarevic V., Nat Immunol., 2017, PMID: 28805812

Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells

Gao Y, Souza-Fonseca-Guimaraes F, Bald T, Ng SS, Young A, Ngiow SF, Rautela J, Straube J, Waddell N, Blake SJ, Yan J, Bartholin L, Lee JS, Vivier E, Takeda K, Messaoudene M, Zitvogel L, Teng MWL, Belz GT, Engwerda CR, Huntington ND, Nakamura K, Hölzel M, Smyth MJ., Nat Immunol., 2017, 18(9):1004-1015, PMID: 28759001

The Abl-1 kinase is dispensable for NK cell inhibitory signaling and is not involved in murine NK cell education

Ganesan S, Thanh TL, Kadri N, Chambers BJ, Meinke S, Brodin P, Vivier E, Wetzel DM, Koleske AJ, Höglund P., Scand J Immunol., 2017, PMID: 28605050

Immune checkpoints on innate lymphoid cells

Chiossone L, Vivier E., J Exp Med., 2017, 214(6):1561-1563, PMID: 28515074

Shifting the balance of activating and inhibitory natural killer receptor ligands on BRAFV600Emelanoma lines with vemurafenib

Frazao A, Colombo M, Fourmentraux-Neves E, Messaoudene M, Rusakiewicz S, Zitvogel L, Vivier E, Vely F, Faure F, Dreno B, Benlalam H, Bouquet F, Savina A, Pasmant E, Toubert A, Avril MF, Caignard A., Cancer Immunol Res., 2017, PMID: 28576831

[Innate lymphoid cells]

Crinier A, Viant C, Girard-Madoux M, Vivier É., Med Sci. (Paris), 2017, 33(5):534-542., PMID: 28612730

Complement factor P is a ligand for the natural killer cell-activating receptor NKp46

Narni-Mancinelli E, Gauthier L, Baratin M, Guia S, Fenis A, Deghmane AE, Rossi B, Fourquet P, Escalière B, Kerdiles YM, Ugolini S, Taha MK, Vivier E., Sci Immunol., 2017, 2(10), PMID: 28480349